-
1Anti-dementia drugs, gait performance and mental imagery of gait : a non-randomized open-label trial
المؤلفون: Sébastien Grenier, Tony Szturm, Louis Bherer, Teresa Liu-Ambrose, Gilles Allali, John M. Barden, Cédric Annweiler, Olivier Beauchet, Victoria L. Chester, Guillaume Léonard
المساهمون: Laboratoire de Psychologie des Pays de la Loire (LPPL), Université d'Angers (UA)-Université de Nantes - UFR Lettres et Langages (UFRLL), Université de Nantes (UN)-Université de Nantes (UN)
المصدر: Drugs and Aging
Drugs and Aging, Adis, 2016, 33 (9), pp.665-673. ⟨10.1007/s40266-016-0391-0⟩
Drugs & Aging, Vol. 33, No 9 (2016) pp. 665-73مصطلحات موضوعية: Male, Gait performance, Mental imagery, Walking, Cohort Studies, [SCCO]Cognitive science, 0302 clinical medicine, Gait (human), Motor imagery, Memantine/administration & dosage/adverse effects/therapeutic use, Receptors, Task Performance and Analysis, 80 and over, Pharmacology (medical), 030212 general & internal medicine, Gait, ComputingMilieux_MISCELLANEOUS, Aged, 80 and over, Memantine, Alzheimer Disease/drug therapy/physiopathology/psychology, 3. Good health, N-Methyl-D-Aspartate/antagonists & inhibitors, Imagination, Female, [SDV.NEU]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC], Alzheimer's disease, Cohort study, medicine.drug, medicine.medical_specialty, Imagination/physiology, STRIDE, Gait/drug effects, Receptors, N-Methyl-D-Aspartate, 03 medical and health sciences, Stride time, Spatio-Temporal Analysis, Physical medicine and rehabilitation, Alzheimer Disease, medicine, Humans, Dementia, Geriatric Assessment, Aged, Walking/physiology/psychology, business.industry, medicine.disease, ddc:616.8, Clinical trial, Physical therapy, Cholinesterase Inhibitors, Geriatrics and Gerontology, Cholinesterase Inhibitors/administration & dosage/adverse effects/therapeutic use, business, human activities, 030217 neurology & neurosurgery